The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Reneuron Group non-executive makes share purchase

Thu, 21st Oct 2021 16:40

(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.
Staehelin, who was appointed as senior independent director at ReNeuron back in July, purchased the shares on Wednesday at an average price of 115.0p each, for a total value of £49,450 each.

Earlier in the week, Reneuron Group said that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

As of 1640 BST, Reneuron shares were up 0.88% at 115.0p each.

Top Director Buys

Jupiter Fund Management (JUP)
Director name: Formica,Andrew
Amount purchased: 360,413 @ 248.41p
Value: £895,301.97

Reneuron Group (RENE)
Director name: Staehelin,Barbara
Amount purchased: 43,000 @ 115.00p
Value: £49,450.00

Emis Group (EMIS)
Director name: Collis,Denise
Amount purchased: 1,441 @ 1,379.58p
Value: £19,879.75

Golden Prospect Precious Metals Ltd. (GPM)
Director name: Burne,Malcolm Alec
Amount purchased: 25,000 @ 46.00p
Value: £11,500.00

Dialight (DIA)
Director name: Oliver,Karen
Amount purchased: 2,698 @ 367.00p
Value: £9,901.66

Dialight (DIA)
Director name: Haug ,Gotthard
Amount purchased: 2,500 @ 369.75p
Value: £9,243.75

Audioboom Group (BOOM)
Director name: Tobin,Michael
Amount purchased: 140 @ 1,030.00p
Value: £1,442.00

Homeserve (HSV)
Director name: Rusin,Tom
Amount purchased: 20 @ 832.50p
Value: £166.50

Homeserve (HSV)
Director name: Harpin,Richard
Amount purchased: 19 @ 832.50p
Value: £158.17

Homeserve (HSV)
Director name: Bower,David
Amount purchased: 19 @ 832.50p
Value: £158.17



Top Director Sells

Jupiter Fund Management (JUP)
Director name: Formica,Andrew
Amount sold: 360,413 @ 248.40p
Value: £895,265.88

Vertu Motors (VTU)
Director name: Crane,David
Amount sold: 281,916 @ 62.45p
Value: £176,056.54

Vertu Motors (VTU)
Director name: Anderson,Karen
Amount sold: 281,916 @ 62.45p
Value: £176,056.54

Capital Limited (di) (CAPD)
Director name: Abery,David
Amount sold: 17,715 @ 84.00p
Value: £14,880.60

More News
23 Nov 2021 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Nov 2021 12:20

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

Read more
26 Oct 2021 19:06

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

Read more
26 Oct 2021 14:02

ReNeuron enters cancer therapy collaboration with UCL

(Sharecast News) - Cell-based therapeutic specialist ReNeuron has entered a collaboration agreement with University College London (UCL), it announced on Tuesday, to conduct research into the generation of immune cells from induced pluripotent stem cells (iPSCs), for anti-cancer cell therapies.

Read more
21 Oct 2021 14:07

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

Read more
18 Oct 2021 15:12

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Read more
18 Oct 2021 09:14

ReNeuron treats first Oxford patient as part of expanded study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group said on Monday that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

Read more
11 Oct 2021 11:51

ReNeuron upbeat on positive data from Spain collaboration

(Sharecast News) - Exosome therapeutics developer ReNeuron announced positive data on Monday that it said provided "clear preclinical proof-of-concept" that its novel exosome drug delivery technology could effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases.

Read more
11 Oct 2021 11:05

IN BRIEF: ReNeuron gets positive results from exosome drug data

IN BRIEF: ReNeuron gets positive results from exosome drug data

Read more
11 Oct 2021 10:59

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
1 Oct 2021 10:33

ReNeuron gets approval to restart RP clinical study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its phase 2a clinical evaluations for the treatment of the inherited, degenerative eye disease retinitis pigmentosa on Friday, confirming that it had received regulatory approval to restart the study in all geographies.

Read more
9 Sep 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.